Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients — ERCO-Park  

Parkinson Disease Clinical Trial

Official title: Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients

Status Completed

Clinical Trial Summary

The consequences of COVID-19 in these already fragile patients should be evaluated. It will be important to appreciate the confinement consequences imposed on the patient on the course and impact of the disease.

These consequences can be assessed by the end of confinement and 6 months after the latter is lifted.

Clinical Trial Description

Adaptation capacities are necessary to cope with the brutal and drastic changes imposed by the pandemic and its consequences. In Parkinson's disease, where there are routine situations with difficulties adjusting to newness, patients in the current situation may be particularly affected and present anxiety due to great difficulties in adaptation.

The repercussions in terms of symptoms (motor and non-motor) of the disease could be very significant. In this population already widely exposed to anxio-depressive symptoms (depression being a common symptom of Parkinson's disease, affecting up to 30 to 40% of patients outside of crisis periods), we can expect a risk increased psychiatric decompensation. The psychiatric consequences could not be limited to the current period but also concern long-term patients, in particular if there is decompensation of other symptoms of the disease (motors, complications linked to treatment, etc.).

The consequences of COVID-19 in these already fragile patients should be evaluated. It will be important to appreciate the confinement consequences imposed on the patient on the course and impact of the disease.

These consequences can be assessed by the end of confinement and 6 months after the latter is lifted.

This is an observational, French multicenter study, of an uncontrolled cohort of parkinsonian patients followed by doctors from Parkinson Expert Centers in hospitals. ;

Related Conditions & MeSH terms

• COVID
• Parkinson Disease

• NCT number: NCT04466839
• Study type: Observational
• Source: University Hospital, Toulouse
• Status: Completed
• Start date: July 2, 2020
• Completion date: December 18, 2020